Publication Name	World Journal of Clinical Oncology
Manuscript ID	61994
Country	United States

Received	2020-12-25 03:17
Peer-Review Started	2020-12-25 03:18
To Make the First Decision
Return for Revision	2021-01-11 03:16
Revised	2021-01-12 19:06
Second Decision	2021-01-25 02:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-02-04 21:56
Articles in Press	2021-02-04 21:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-02-14 02:44
Publish the Manuscript Online	2021-02-22 12:47

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Opinion Review
Article Title	Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?
Manuscript Source	Invited Manuscript
All Author List	Maitham A Moslim, Michael J Hall, Joshua E Meyer and Sanjay S Reddy
Funding Agency and Grant Number
Corresponding Author	Sanjay S Reddy, FACS, MD, Attending Doctor, Department of Surgery, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States. sanjay.reddy@fccc.edu
Key Words	Pancreatic cancer; COVID-19; Medical oncology; Radiation; Neoadjuvant therapy; Pancreatic adenocarcinoma
Core Tip	Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population; Oncological treatment protocols must adapt to the coronavirus disease 2019 era; Neoadjuvant treatment and further conducting a safe surgery while protecting patients in a controlled environment can improve oncological outcomes.
Publish Date	2021-02-22 12:47
Citation	Moslim MA, Hall MJ, Meyer JE, Reddy SS. Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils? World J Clin Oncol 2021; 12(2): 54-60
URL	https://www.wjgnet.com/2218-4333/full/v12/i2/54.htm
DOI	https://dx.doi.org/10.5306/wjco.v12.i2.54

Full Article (PDF)	WJCO-12-54.pdf
Full Article (Word)	WJCO-12-54.docx
Manuscript File	61994_Auto_Edited_LM.docx
Answering Reviewers	61994-Answering reviewers.pdf
Audio Core Tip	61994-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	61994-Conflict-of-interest statement.pdf
Copyright License Agreement	61994-Copyright license agreement.pdf
Peer-review Report	61994-Peer-review(s).pdf
Scientific Misconduct Check	61994-Scientific misconduct check.pdf
Scientific Editor Work List	61994-Scientific editor work list.pdf